Real-time enrollment status for this urothelial carcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:03 PM UTC
| NCT Number | NCT05874921 |
| Recruiting Status | Recruiting |
| Condition | Urothelial Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 450 participants |
| Active Locations | 22 sites in the US |
| Sponsor | UroGen Pharma Ltd. |
| Last Updated on CT.gov | September 29, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT05874921 is currently recruiting participants. This clinical trial study for urothelial carcinoma is actively seeking new participants at 22 locations across the United States. The study is sponsored by UroGen Pharma Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05874921 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05874921 was last updated 1 week ago (September 29, 2026). HelloStudys verifies this status automatically.